The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

Share Price Information for Versarien (VRS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.1005
Bid: 0.093
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.01 (10.753%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.1005
VRS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Placing to raise £615,000

20 Mar 2024 08:33

RNS Number : 5860H
Versarien PLC
20 March 2024
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET ABUSE REGULATION (EU) 596/2014 (AS AMENDED) AS IT FORMS PART OF THE DOMESTIC LAW OF THE UNITED KINGDOM BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 (AS AMENDED). UPON PUBLICATION OF THIS ANNOUNCMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

20 March 2024

 

Versarien plc

 

("Versarien" or the "Company")

 

Placing to raise £615,000

 

Versarien plc (AIM: VRS), the advanced materials engineering group, announces it has raised £615,000 (before expenses) by way of a placing (the "Placing") of 492,000,000 new ordinary shares in the capital of the Company ("Placing Shares") at a price of 0.125 pence per share (the "Placing Price").

 

Highlights

 

? Versarien has raised £615,000, before expenses, through the placing of 492,000,000 new ordinary shares at a price of 0.125 pence per share

 

? The net proceeds of the Placing will be used for corporate and working capital purposes as the Company continues to progress its turnaround strategy following the recent sale of its South Korean assets and licencing agreement with Montana Química LTDA ("Montana")

 

? The issue of the Placing Shares utilises the remaining authorities granted by shareholders at the general meeting of the Company held on 10 January 2024 and therefore no shareholder approval is required for the Placing

 

Use of Proceeds and Turnaround Strategy

 

The net proceeds of the Placing will be used for corporate and working capital purposes as the Company continues to implement its turnaround strategy. The recent announcements regarding the sale of Versarien's South Korean assets and licencing of IP to MCK Tech Co. Ltd, plus the licencing agreement with Montana provide the Versarien board with additional confidence that the strategy is working. The Company continues to pursue a variety of commercial opportunities in its target markets of construction and leisure, and in other areas.

 

As announced on 11 March 2024, the Company's mature businesses, AAC Cyroma Limited and Total Carbide Limited, continue to be marketed for sale and the Company is progressing discussions with interested parties.

 

Stephen Hodge, Chief Executive Officer of Versarien, commented:

 

"We are very pleased to have raised these funds which will facilitate further progress following the positive developments regarding the sale of the South Korean assets and licencing deal with Montana, and will assist in laying the foundations for us to implement a longer-term strategy for the business. We look forward to providing further updates in due course."

 

Admission and Total Voting Rights

 

Application has been made for admission of the Placing Shares to be admitted to trading on AIM ("Admission") on or around 25 March 2024. The Placing Shares will rank pari passu in all respects with the Company's existing ordinary shares. Following Admission, the total number of ordinary shares in the Company in issue will be 1,488,169,507. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure and Transparency Rules.

 

For further information please contact:

 

Versarien

Stephen Hodge, Chief Executive Officer

Chris Leigh, Chief Financial Officer

 

c/o IFC

SP Angel Corporate Finance (Nominated Adviser and Broker)

Matthew Johnson, Adam Cowl

+44 (0)20 3470 0470

 

 

IFC Advisory Limited (Financial PR and Investor Relations)

Tim Metcalfe, Zach Cohen

+44 (0) 20 3934 6630

 

About Versarien:

 

The strategy of Versarien plc (AIM:VRS) is to be a development led advanced materials company focussed on specific sectors that will lead to a light manufacturing and licensing model.

 

For further information please see: http://www.versarien.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEPPUPWWUPCURU
Date   Source Headline
12th Feb 20204:35 pmRNSPrice Monitoring Extension
11th Feb 20204:40 pmRNSSecond Price Monitoring Extn
11th Feb 20204:36 pmRNSPrice Monitoring Extension
11th Feb 20202:05 pmRNSSecond Price Monitoring Extn
11th Feb 20202:00 pmRNSPrice Monitoring Extension
11th Feb 202011:05 amRNSSecond Price Monitoring Extn
11th Feb 202011:00 amRNSPrice Monitoring Extension
10th Feb 20207:00 amRNSResponse to share price movement
21st Jan 20207:00 amRNSUS Update
18th Dec 20197:00 amRNSAirbus Graphene Flagship Project
12th Dec 20197:00 amRNSInterim Results
27th Nov 20197:00 amRNSNotice of Results
27th Nov 20197:00 amRNSTextile Commercial Partnership Agreement
1st Nov 20192:05 pmRNSSecond Price Monitoring Extn
1st Nov 20192:00 pmRNSPrice Monitoring Extension
9th Oct 20197:00 amRNSRefractory Materials Collaboration
24th Sep 20191:38 pmRNSResult of AGM
24th Sep 20197:00 amRNSAGM Statement
20th Sep 201911:47 amRNSSecond Price Monitoring Extn
20th Sep 201911:46 amRNSPrice Monitoring Extension
19th Sep 20192:05 pmRNSSecond Price Monitoring Extn
19th Sep 20192:00 pmRNSPrice Monitoring Extension
22nd Aug 20199:35 amRNSAppointment of Joint Broker
21st Aug 20191:35 pmRNSNotice of AGM and Posting of Annual Report
9th Aug 20197:54 amRNSChina Update and Clarification
6th Aug 20197:00 amRNSAnnual General Meeting
26th Jul 20197:00 amRNSLOI with Global Apparel Manufacturer
24th Jul 20197:00 amRNSTransport Infrastructure Technology Preview Event
17th Jul 20197:00 amRNSPreliminary Results
16th Jul 20197:00 amRNSInvestor Event
15th Jul 20198:00 amRNSReceipt of Graphene REACH Registration
11th Jul 201910:30 amRNSNotice of Results
8th Jul 20197:00 amRNSJapanese Graphene Order
1st Jul 20197:00 amRNSAppointment of Director
28th Jun 20197:00 amRNSUS Graphene Order
27th Jun 20192:33 pmRNSAppointment of New Head of US Operations
19th Jun 20192:16 pmRNSResponse to Commentary Regarding US Employee
29th May 20193:00 pmRNSCollaboration Agreement with BP Polymers
9th May 20197:00 amRNSUSA Update
15th Apr 20196:03 pmRNSDirector/PDMR Shareholding
15th Apr 20197:00 amRNSTerm Sheet with Beijing Institute of Graphene Tech
4th Apr 20198:29 amRNSUS Appointment Update
1st Apr 20197:00 amRNSCompletion of Verified Graphene Producer Programme
29th Mar 20197:00 amRNSExtension of DIT Secondment
21st Mar 20197:00 amRNSUSA Update
14th Mar 20197:00 amRNSLOI with Tunghsu Optoelectronic
7th Mar 201911:42 amRNSFurther Chinese Aerospace Collaboration
5th Mar 20199:00 amRNSPrice Monitoring Extension
1st Mar 20192:05 pmRNSSecond Price Monitoring Extn
1st Mar 20192:00 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.